{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:20:09Z","timestamp":1789179609619,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004477","name":"US Public Health Service","doi-asserted-by":"publisher","award":["MH106640"],"award-info":[{"award-number":["MH106640"]}],"id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011411","name":"University of South Dakota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pnpbp.2019.109754","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T10:35:44Z","timestamp":1566642944000},"page":"109754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice"],"prefix":"10.1016","volume":"96","author":[{"given":"Dayalan","family":"Sampath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"McWhirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sathyanesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7354","key":"10.1016\/j.pnpbp.2019.109754_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109754_bb0010","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.biopsych.2005.11.003","article-title":"The role of CREB in depression and antidepressant treatment","volume":"59","author":"Blendy","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109754_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0278-5846(98)00009-8","article-title":"Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages","volume":"22","author":"Bourin","year":"1998","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"15","key":"10.1016\/j.pnpbp.2019.109754_bb0020","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1073\/pnas.0601377103","article-title":"Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities","volume":"103","author":"Coleman","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109754_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050327","article-title":"Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies","volume":"132","author":"Crawley","year":"1997","journal-title":"Psychopharmacology"},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2019.109754_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109754_bb0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2018.17121368","article-title":"Role of neuronal VEGF Signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine","volume":"176","author":"Deyama","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2019.109754_bb0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","article-title":"Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test","volume":"29","author":"Dulawa","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.pnpbp.2019.109754_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2019.109754_bb0050","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"Ehrenreich","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.109754_bb0055","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0896-6273(00)80395-5","article-title":"CREB: a major mediator of neuronal neurotrophin responses","volume":"19","author":"Finkbeiner","year":"1997","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109754_bb0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/toxsci\/62.2.250","article-title":"C57BL\/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivity","volume":"62","author":"Flint","year":"2001","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109754_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.biopsych.2008.12.005","article-title":"Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects","volume":"66","author":"Girgenti","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109754_bb0070","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2019.109754_bb0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.neuropharm.2010.09.025","article-title":"Comparison of the effects of erythropoietin and its carbamylated derivative on behaviour and hippocampal neurogenesis in mice","volume":"60","author":"Leconte","year":"2011","journal-title":"Neuropharmacology"},{"issue":"5681","key":"10.1016\/j.pnpbp.2019.109754_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science (New York, N.Y.)"},{"issue":"67","key":"10.1016\/j.pnpbp.2019.109754_bb0085","doi-asserted-by":"crossref","DOI":"10.3791\/4389","article-title":"Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification","author":"McLean","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"11","key":"10.1016\/j.pnpbp.2019.109754_bb0090","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biopsych.2007.01.011","article-title":"Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action","volume":"62","author":"Miskowiak","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109754_bb0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.npp.1301439","article-title":"Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration","volume":"33","author":"Miskowiak","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109754_bb0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-011-2511-1","article-title":"Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression","volume":"219","author":"Miskowiak","year":"2012","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109754_bb0105","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/npp.2013.335","article-title":"Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"39","author":"Miskowiak","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109754_bb0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biopsych.2014.12.013","article-title":"Effects of erythropoietin on hippocampal volume and memory in mood disorders","volume":"78","author":"Miskowiak","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"24","key":"10.1016\/j.pnpbp.2019.109754_bb0115","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1523\/JNEUROSCI.22-24-10883.2002","article-title":"Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect","volume":"22","author":"Newton","year":"2002","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.pnpbp.2019.109754_bb0120","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00018-013-1281-9","article-title":"Vascular growth factors in neuropsychiatry","volume":"70","author":"Newton","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109754_bb0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.biopsych.2018.08.021","article-title":"The Hippocampus in depression: more than the sum of its parts? Advanced hippocampal substructure segmentation in depression","volume":"85","author":"Roddy","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2019.109754_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41398-018-0168-9","article-title":"Carbamoylated erythropoietin modulates cognitive outcomes of social defeat and differentially regulates gene expression in the dorsal and ventral hippocampus","volume":"8","author":"Sathyanesan","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2019.109754_bb0135","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2019.109754_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pnpbp.2018.07.011","article-title":"Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells","volume":"88","author":"Tiwari","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619302271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619302271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T10:09:38Z","timestamp":1573639778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619302271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":28,"alternative-id":["S0278584619302271"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109754","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109754"}}